Skip to main content
. 2018 Jan 3;9(16):12682–12694. doi: 10.18632/oncotarget.23913

Figure 6. Effect of cisplatin on endometrial cancer cell survival rate.

Figure 6

The result of flow cytometry after treated with cisplatin in HEC-1A (A), HEC-1B (B), RL952 (C) cell respectively. (D) The survival rate of HEC-1A, HEC-1B, RL952 cells were decreased with the increasing concentration of cisplatin.